Effect of sinomenine on vascular smooth muscle cell dedifferentiation and neointima formation after vascular injury in mice

详细信息    查看全文

• 作者：Lihua Zhu (1) (2)
  Yarong Hao (3)
  Hongjing Guan (1) (2)
  Changping Cui (1) (2)
  Song Tian (1) (2)
  Da Yang (1) (2)
  Xinan Wang (1) (2)
  Shuming Zhang (1) (2)
  Lang Wang (1) (2)
  Hong Jiang (1) (2)
  
• 关键词：Sinomenine ; Vascular smooth muscle cell ; Neointima formation ; Platelet ; derived growth factor
• 刊名：Molecular and Cellular Biochemistry
• 出版年：2013
• 出版时间：2 - January 2013
• 年：2013
• 卷：373
• 期：1
• 页码：53-62
• 全文大小：737KB
• 参考文献：1. Doran AC, Meller N, McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28:812-19 CrossRef
  2. Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767-01 CrossRef
  3. Hao H, Gabbiani G, Bochaton-Piallat ML (2003) Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 23:1510-520 CrossRef
  4. Mack CP (2011) Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 31:1495-505 CrossRef
  5. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460:705-10
  6. Wang Q, Li XK (2011) Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol 11:373-76 CrossRef
  7. Long LH, Wu PF, Chen XL, Zhang Z, Chen Y, Li YY, Jin Y, Chen JG, Wang F (2010) HPLC and LC-MS analysis of sinomenine and its application in pharmacokinetic studies in rats. Acta Pharmacol Sin 31:1508-514 CrossRef
  8. Yamasaki H (1976) Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum. Acta Med Okayama 30:1-0
  9. Cheng Y, Zhang J, Hou W, Wand D, Li F, Zhang Y, Yuan F (2009) Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis. Int Immunopharmacol 9:894-99 CrossRef
  10. Liu L, Resch K, Kaever V (1994) Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int J Immunopharmacol 16:685-91 CrossRef
  11. Hojo H, Kondo Y, Umeda H, Tahira T, Hashimoto Y (1985) Effect of sinomenine on antibody responses in mice. J Immunopharmacol 7:33-2 CrossRef
  12. Kim HM, Moon PD, Chae HJ, Kim HR, Chung JG, Kim JJ, Lee EJ (2000) The stem of Sinomenium acutum inhibits mast cell-mediated anaphylactic reactions and tumor necrosis factor-alpha production from rat peritoneal mast cells. J Ethnopharmacol 70:135-41 CrossRef
  13. Nishida S, Satoh H (2006) In vitro pharmacological actions of sinomenine on the smooth muscle and the endothelial cell activity in rat aorta. Life Sci 79:1203-206 CrossRef
  14. Wang L, Zhu LH, Jiang H, Tang QZ, Yan L, Wang D, Liu C, Bian ZY, Li H (2010) Grape seed proanthocyanidins attenuate vascular smooth muscle cell proliferation via blocking phosphatidylinositol 3-kinase-dependent signaling pathways. J Cell Physiol 223:713-26
  15. Zhu LH, Wang L, Wang D, Jiang H, Tang QZ, Yan L, Bian ZY, Wang XA, Li H (2010) Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2/Rac1-dependent signaling. Free Radic Biol Med 48:471-82 CrossRef
  16. Li L, Zhang HN, Chen HZ, Gao P, Zhu LH, Li HL, Lv X, Zhang QJ, Zhang R, Wang Z, She ZG, Zhang R, Wei YS, Du GH, Liu DP, Liang CC (2011) SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circ Res 108:1180-189 CrossRef
  17. Jiang T, Zhou L, Zhang W, Qu D, Xu X, Yang Y, Li S (2010) Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro. Mol Med Report 3:51-6
  18. Shu L, Yin W, Zhang J, Tang B, Kang YX, Ding F, Hua ZC (2007) Sinomenine inhibits primary CD4?+?T-cell proliferation via apoptosis. Cell Biol Int 31:784-89 CrossRef
  19. He X, Wang J, Guo Z, Liu Q, Chen T, Wang X, Cao X (2005) Requirement for ERK activation in sinomenine-induced apoptosis of macrophages. Immunol Lett 98:91-6 CrossRef
  20. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN (2004) Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428:185-89 CrossRef
  21. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, Aoki J, Arai H, Sobue K (2001) Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 89:251-58 CrossRef
  22. Yamaguchi H, Igarashi M, Hirata A, Sugae N, Tsuchiya H, Jimbu Y, Tominaga M, Kato T (2004) Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta. Arterioscler Thromb Vasc Biol 24:2095-101 CrossRef
  23. Yu K, Zheng B, Han M, Wen JK (2011) ATRA activates and PDGF-BB represses the SM22α promoter through KLF4 binding to, or dissociating from, its cis-DNA elements. Cardiovasc Res 90:464-74 CrossRef
  24. Miyake H, Maeda K, Asai N, Shibata R, Ichimiya H, Isotani-Sakakibara M, Yamamura Y, Kato K, Enomoto A, Takahashi M, Murohara T (2011) The actin-binding protein Girdin and its Akt-mediated phosphorylation regulate neointima formation after vascular injury. Circ Res 108:1170-179 CrossRef
  25. Hegner B, Lange M, Kusch A, Essin K, Sezer O, Schulze-Lohoff E, Luft FC, Gollasch M, Dragun D (2009) mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors. Arterioscler Thromb Vasc Biol 29:232-38 CrossRef
  26. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, Kitabatake A, Aoki J, Arai H, Sobue K (2001) Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res 89:251-58 CrossRef
  27. Kaimoto T, Yasuda O, Ohishi M, Mogi M, Takemura Y, Suhara T, Ogihara T, Fukuo K, Rakugi H (2010) Nifedipine inhibits vascular smooth muscle cell dedifferentiation via downregulation of Akt signaling. Hypertension 56:247-52 CrossRef
  28. Deb A, Zamanian-Daryoush M, Xu Z, Kadereit S, Williams BR (2001) Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. The EMBO 20:2487-496 CrossRef
  29. Wang D, Liu Z, Li Q, Karpurapu M, Kundumani-Sridharan V, Cao H, Dronadula N, Rizvi F, Bajpai AK, Zhang C, Müller-Newen G, Harris KW, Rao GN (2007) An essential role for gp130 in neointima formation following arterial injury. Circ Res 100:807-16 CrossRef
  30. Seki Y, Kai H, Shibata R, Nagata T, Yasukawa H, Yoshimura A, Imaizumi T (2000) Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res 87:12-8 CrossRef
  31. Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276-312 CrossRef
  32. Wang YZ, Wharton W, Garcia R, Kraker A, Jove R, Pledger WJ (2000) Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity. Oncogene 19:2075-085 CrossRef
  
• 作者单位：Lihua Zhu (1) (2)
  Yarong Hao (3)
  Hongjing Guan (1) (2)
  Changping Cui (1) (2)
  Song Tian (1) (2)
  Da Yang (1) (2)
  Xinan Wang (1) (2)
  Shuming Zhang (1) (2)
  Lang Wang (1) (2)
  Hong Jiang (1) (2)
  
  1. Department of Cardiology, Renmin Hospital of Wuhan University, JieFang Road 238, Wuhan, 430060, People’s Republic of China
  2. Cardiovascular Research Institute of Wuhan University, Wuhan, 430060, People’s Republic of China
  3. Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China
  
• ISSN：1573-4919

文摘

Sinomenine, a pure alkaloid extract from Sinomenium acutum, has anti-inflammatory and immunoregulatory functions. This study investigated the efficiency and the signalling pathways involved in the effect of sinomenine on vascular smooth muscle cell (VSMC) dedifferentiation in response to platelet-derived growth factor (PDGF)-BB stimulation and vascular injury. VSMCs were isolated from rat aorta and preincubated with sinomenine before being stimulated with PDGF-BB. WST and BrdU incorporation assays were used to evaluate VSMC proliferation. Flow cytometric analysis was performed for testing the cell cycle progression. The cell migration of VSMCs were analysed using a Transwell system. The expression of VSMC specific genes and signalling proteins were tested by Western blot. For the animal study, C57/BL6 mice were fed either normal rodent chow diets or sinomenine chow diets that supplemented with 0.09?% sinomenine (w/w) in the normal chows for 14?days before carotid artery wire injury. PDGF-BB activated the dedifferentiation of VSMCs characterised by decreased expression of SMA, Smoothelin and SM22α. However, sinomenine treatment preserved the dedifferentiation in response to PDGF-BB. The activations of mitogen-activated protein kinase extracellular signal-regulated kinases, Akt, GSK3β and STAT3 induced by PDGF-BB were also inhibited in sinomenine-treated VSMCs. In vivo evidence with wire-injured mice exhibited a reduction in neointimal area and an increase in smooth muscle-specific gene expression in the sinomenine-treated group. In this study, we found that sinomenine-suppressed VSMC phenotype switching induced by PDGF-BB in vitro and neointimal formation in vivo. Therefore, sinomenine is a potential candidate to be used in the treatment of vascular proliferative disease.